Fuensanta Bellvís Bataller, VP of Clinical Studies at Quibim, shared on LinkedIn:
“ESMO 2026 has kicked off!
This year, the oncology community comes together here in Madrid, and the Quibim team is ready for a few days of science, inspiring conversations, and new ideas to better characterise patients and support smarter decision-making in oncology clinical trials.
Come and meet us at booth 8052, or send me a message to arrange a meeting. Let’s explore how we can work together!
Looking forward to connecting with you these days.”
Other articles about ESMO 2026 on OncoDaily.